Quality
Chemicals Industrial Limited (QCIL), Uganda’s only pharmaceutical producing
plant based in Luzira is to start producing Duomune, a new antiretroviral drug.
Duomune, according to the World Health Organization (WHO)
is indicated in combination with at least one other antiretroviral medication
for the treatment of the HIV infection. It is a fixed dose combination of
tenofovir disoproxil fumarate and lamivudine. The recommended dose of Duomune is
one tablet, taken orally, once daily. In order to optimise the absorption of
tenofovir, it is recommended that Duomune be taken with food.
“The new drug is going to reduce the burden of taking ARVs
many times a day as it will be taken only once,” Samuel Opio, the plant’s
pharmacist said in an interview.
WHO
recommends Duomune as a first line treatment for HIV infections in infected adults over 18 years of age.
The drug is not recommended for
use in children and adolescents below 18 years due to insufficient data on
safety and efficacy.
Emmanuel
Katongole, the executive director Quality Chemicals says production is due to
begin in three months after National Drug Authority (NDA) approved of the drug
and production procedure.
The cost of
Duomune’s monthly dose is yet to be established.
Meanwhile, the anti corruption coalition wants government to take
action against quality chemicals for breach of contract and inflating the
prices of ARVs and anti malarials sold to government.
Cissy Kagaba the executive director Anti corruption coalition alleges
that Quality Chemicals has breached the agreement to manufacture all drugs here
as only 16% is manufactured and the rest imported. She adds that in order to
fulfil its contracts for the drugs, Quality Chemical started importing Cipla's
ACT Lumartem, an antimalarial therapy instead of producing it.
“According to the 2011 IGG
report, Quality Chemicals has been acting as a middleman for government to
purchase drugs abroad but instead they have inflated prices causing a shs. 44
billion loss,” Kagaba said.
However Katongole has dismissed the allegations saying they are
false and aim at spoiling the company’s image.